Baxter-JPM-20240108.pdf

1、42NDANNUAL J.P.MORGAN HEALTHCARE CONFERENCEJos(Joe)AlmeidaChairman&Chief Executive Of ficerJ A N U A R Y 8,2 0 241This presentation includes forward-looking statements concerning the companys financial results,2022 2025 market growth rates,business development and regulatory activities and the compa

2、nys ongoing strategic actions.These forward-looking statements are based on assumptions about many important factors,including the following,which could cause actual results to differ materially from those in the forward-looking statements:the companys ability to execute and complete strategic initi

3、atives,asset dispositions and other transactions,including the planned separation of the companys Kidney Care segment and the companys ongoing work to simplify its manufacturing footprint,the timing for such transactions,the ability to satisfy any applicable conditions and the expected proceeds,cons

4、ideration and benefits;failure to accurately forecast or achieve the companys short-and long-term financial improvement performance and goals(including with respect to the companys strategic actions);the companys ability to execute on its capital allocation plans,including the companys debt repaymen

5、t plans,the timing and amount of any dividends,share repurchases and acquisition proceeds and the capital structure of the company that the company expects to form as a result of the planned separation(and the resulting capital structure for the remaining company);the impact of global economic condi

6、tions(including,among other things,inflation levels,interest rates,financial market volatility,banking crises,the potential for a recession,the ongoing wars in Ukraine,Israel and Gaza and other geopolitical events,the related economic sanctions being imposed globally in response to the conflicts and